11 March 2024 Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility
26 February 2024 Akston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility
9 February 2021 Akston Biosciences Completes Second Licensing and Supply Agreement with Dechra Pharmaceuticals PLC